Introducing Trial Ripeness Radar
The Trial Ripeness Radar brings together signals from multiple industry sources and scores potential study opportunities to help your team identify when it may be time to act.
Discover opportunities earlier in the study lifecycle, understand which trials deserve your attention, find the right contacts, and manage your pursuit through study startup.
Find opportunities. Understand readiness. Connect with decision makers. Manage your pipeline.
Product screenshots show staging data. October 14, 2026 snapshot; modeled values are estimates, not contracted or realized revenue. Figures change over time.
See the signals that may indicate when a trial is ready to pursue.
Clinical trial opportunities often begin taking shape in sponsor announcements, development pipelines, regulatory activity, and other industry sources well before site selection is complete. Trial Ripeness Radar brings those signals together, evaluates the opportunity, and helps your team determine which studies may be worth pursuing now.
01 · Discover
02 · Score
03 · Prioritize
04 · Pursue
05 · Convert
Know which trials are ready for your site.
Every tracked trial receives a ripeness score from 0 to 100. As new signals emerge, the score updates to help your team distinguish opportunities that may be ready to pursue from those worth continuing to monitor.
Eight-stage opportunity funnel · 33 therapeutic areas · Coverage across the US, Canada, EU and UK.
Hot · 80–100 — strongest ripeness signals for site selection and activation.
Warm · 60–79 — promising opportunities with signals still developing.
Watch · 40–59 — early opportunities worth monitoring.
Cold · 0–39 — limited ripeness signals today.
Confidence reflects the strength of the supporting evidence and is separate from the readiness score. Confidence levels: High · Medium · News only
Multiple intelligence sources. One actionable picture.
Trial Ripeness Radar brings together signals from industry news, regulatory filings, sponsor pipelines and websites, ClinicalTrials.gov, and the European CTIS registry. By evaluating these sources together, SiteCentric gives business development teams a clearer picture of where an opportunity may be in its lifecycle and whether it may be worth pursuing.
Industry news & press releases · SEC EDGAR · Sponsor pipelines · Sponsor websites · ClinicalTrials.gov · CTIS
Radar also indicates the strength of the supporting evidence, helping your team distinguish early signals from opportunities supported by regulatory or registry data.
Source availability and coverage may vary by opportunity.
Dashboard — Industry news alongside your BD activity
Focus your team on the right study opportunities.
Filter opportunities by indication, geography, study phase, study role, expected timing, and CRO involvement. Save the searches your team uses most and exclude opportunities that do not fit your investigators or sites.
Each opportunity can also include an estimated per-site value range and modeled expected value based on assumptions your team can adjust, helping you weigh potential financial value alongside strategic fit.
Estimates are intended for planning purposes and do not represent guaranteed revenue.
Understand a protocol before you commit.
SiteCentric uses AI to analyze key protocol details such as screen-failure risk, projected patient visits, equipment needs, and financial considerations to help your team assess operational and financial feasibility before committing to a study.
AI-assisted analysis helps surface important considerations for review by your team. It does not replace site judgment or make automated study decisions.
Query Studies — Protocol search
From first signal to study start. One connected workflow.
Move promising Radar opportunities into your business development pipeline, assign ownership and next steps, and track each pursuit through startup and activation. Give site and network leadership a shared view of what is moving, what needs attention, and what comes next.
BD Overview — Funnel, indications, sponsor/CRO context
Leads — Organize leads, sponsor, indication, phase, and current status
Follow-Ups — Manage assignees and due dates
Study Starts — Track progress and pursuit status by site
Pipeline by site — Study status and site-level opportunities
Know the opportunity. Find the right people.
Optional Apollo-powered contact discovery helps your team identify relevant sponsor and CRO contacts connected to the opportunities you want to pursue. Use it when needed, pay only for what you use, and control costs with a monthly spend cap.
Premium add-on · Pay per use · No separate Apollo subscription required
Keep sponsor and CRO contacts connected to your broader SiteCentric CRM workflow.
How is Trial Ripeness calculated?
A 0–100 opportunity-readiness score; Hot, Warm, Watch and Cold levels change as new evidence appears.
Can I identify trials before registration?
Yes, when earlier sponsor, news, press-release or filing signals are available; they carry explicit confidence labels.
Which sources does SiteCentric monitor?
News/press releases, SEC EDGAR, sponsor pipelines and accessible sponsor websites, ClinicalTrials.gov and CTIS.
Does the platform include a CRM?
Yes. Dashboard, Leads, Follow-Ups, Study Starts, Query Studies and BD Contacts in one workflow.
Can I assess a study’s potential value?
Yes. Per-site value ranges and expected values are modeled from adjustable assumptions and are not guaranteed revenue.
Does SiteCentric help review protocols?
Yes. Supported AI-powered analysis includes screening considerations, projected visits, equipment needs and financial risk.
How much does it cost?
$1,000/month with unlimited users and trial leads and no signup or onboarding fee. Apollo usage, if enabled, is separate.
Is Apollo required?
No. Optional premium add-on, pay per use with no monthly subscription fee and a client-controlled monthly spending cap.
